Keywords: proethics, reports, strong, ph, iii, data, pro-513

ProEthics reports strong Ph III data for PRO-513

Article | 15 January 2007

Print This

The USA's ProEthic Pharmaceuticals has reported strong Phase III trial results for PRO-513, its product candidate for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in